Published in Acta Virol on March 01, 1973
Immunodiffusion studies on the reaction of influenza virus with specific antibody and nonspecific serum beta-inhibitor. Acta Virol (1966) 1.45
Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology (1996) 1.30
Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. Acta Virol (1987) 1.10
The use of rivanol treatment for removal from sera of nonspecific inhibitors of enterovirus and reovirus hemagglutination. Am J Epidemiol (1968) 1.07
Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol (2001) 0.92
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. II. Reactivity with rabbit sera against intact virus and purified undissociated haemagglutinin. Acta Virol (1978) 0.90
Immunodiffusion reactions with rubella antigens. J Immunol (1968) 0.89
Inhibition of the antiviral action of interferon by tick salivary gland extract. Parasite Immunol (2000) 0.88
Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. Arch Virol (1988) 0.88
Salivary gland extracts of partially fed Dermacentor reticulatus ticks decrease natural killer cell activity in vitro. Immunology (1994) 0.88
Heterogeneity in the effect of different ixodid tick species on human natural killer cell activity. Parasite Immunol (2002) 0.86
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. Acta Virol (1979) 0.86
Antibody against Hong Kong influenza viruses in pigs. Acta Virol (1971) 0.86
Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha. Acta Virol (1989) 0.86
Antibody response to natural influenza A2 infection of man as studied by gel double diffusion. Acta Virol (1968) 0.85
An interferon like substance induced by mannans. Acta Virol (1967) 0.85
Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong 1-68 influenza viruses. I. The course of infection and virus recovery. Acta Virol (1969) 0.83
Tick salivary gland extracts promote virus growth in vitro. Parasitology (1998) 0.83
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol (1979) 0.83
Antibody response of guinea pigs and white mice to nucleoprotein component of influenza virus as studied by gel double diffusion. Acta Virol (1968) 0.82
The effect of postfusion cell density on establishment of hybridomas. Folia Biol (Praha) (1988) 0.82
Double-stranded f 2 phage RNA as interferon inducer. Acta Virol (1971) 0.82
Enhancing effect of anti-endotoxic serum on interferon induction in mouse peritoneal cells by endotoxin. Acta Virol (1968) 0.81
Release of interferon by mouse peritoneal cells in vitro. The requirement of contact with endotoxin and the temperature dependence of release. Acta Virol (1969) 0.81
Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha. Immunology (1991) 0.81
Electrophoretic profiles and activities of human interferon in heterologous cells. Intervirology (1974) 0.81
Prevention of spontaneous autoimmunity to DNA in NZB/Swiss mice by treatment with natural double-stranded RNA. Immunology (1975) 0.81
Characterization of influenza A-1983 epidemic strains by polyclonal and monoclonal antibodies and detection of two co-circulating antigenic variants. Acta Virol (1986) 0.79
A novel Notch3 Gly89Cys mutation in a Serbian CADASIL family. Acta Neurol Belg (2013) 0.79
Activation of NK cells in subjects exposed to mild hyper- or hypothermic load. J Interferon Res (1988) 0.79
Periodicity of interferon appearance in serum of patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.78
Activation of the complement system by interferon inducers. Acta Virol (1972) 0.78
Experimental pathogenesis of A-equi 1 influenza virus infection in horses. Acta Virol (1966) 0.78
Interferon as therapeutic agent. Acta Virol (1983) 0.78
Promotion of vesicular stomatitis virus nucleocapsid protein production by arthopod saliva. Acta Virol (1999) 0.78
Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats. Am J Med Sci (2000) 0.78
The reticuloendothelial system and virus infection. II. Production of interferon- and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch Gesamte Virusforsch (1965) 0.78
Interferon alpha2b is the predominant subvariant detected in human genomic DNAs. Acta Virol (1994) 0.78
Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon. Acta Virol (1986) 0.78
Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions. Acta Virol (1975) 0.78
The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol (1967) 0.78
Human acid- and thermolabile alpha-interferon-like substance: selective reactivity with a monoclonal antibody. Antiviral Res (1989) 0.78
Comparison of manganese superoxide dismutase precursor induction ability in human hepatoma cells with or without hepatitis B virus DNA insertion. Acta Virol (2000) 0.77
Are the acid-labile interferon alpha and interferon omega-1 identical? Virology (1991) 0.77
Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol (1972) 0.77
Interaction of plasma membranes with influenza virus. II. Release of viral nucleoprotein. Acta Virol (1971) 0.77
Therapeutic use of double-stranded RNAs in man. Tex Rep Biol Med (1983) 0.77
The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Neoplasma (1977) 0.77
Cross-species antiviral and antiproliferative activity of human interferon-omega. J Interferon Res (1994) 0.77
Affinity chromatography of mouse interferon: a modified purification procedure utilizing specifically purified antibodies. Acta Virol (1976) 0.77
Current view on the perspectives of interferon therapy. Acta Virol (1986) 0.77
Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Acta Virol (1989) 0.77
Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Acta Virol (1989) 0.76
Peptide-mapping of three neutralizing epitopes into predicted biologically active sites of human interferon-alpha 2. Immunol Lett (1993) 0.76
Effect of impulsin treatment of interferon production and antiviral resistance of mice. Arch Immunol Ther Exp (Warsz) (1977) 0.76
[N[2-hydroxyethyl] palmitamide repeated administration effect on interferon production in mouse organism after phage double-stranded ribonucleic acid [ds-RNA] application (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1978) 0.76
Stimulation of interferon production by mannans. Proc Soc Exp Biol Med (1970) 0.76
Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Mol Immunol (1992) 0.76
Blood-brain barrier permeability changes during acute allergic encephalomyelitis induced in the guinea pig. Metab Brain Dis (1989) 0.76
Interferon alpha-induced modulation of leukocyte cell surface antigens: immunocytofluorometric study with human leukaemia/lymphoma cell lines. Acta Virol (1991) 0.76
Vesicular stomatitis virus nucleocapsid protein production in cells treated with selected fast protein liquid chromatography fractions of tick salivary gland extracts. Acta Virol (2002) 0.75
Interactions between viral infection and immune mechanisms. Comp Immunol Microbiol Infect Dis (1980) 0.75
Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med (1977) 0.75
Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp (Warsz) (1995) 0.75
Production of interferon and other lymphokines during murine tumour growth. I. Lymphokines in cell--free fluid of rat Zajdela ascites hepatoma. Acta Virol (1980) 0.75
Antiviral and anticellular effects of interferon on the mouse embryonic cells transformed by viruses and/or chemical carcinogen. Acta Biol Med Ger (1979) 0.75
Production of human leukocyte interferon for clinical use under immunoelectrophoretic control. Acta Biol Med Ger (1979) 0.75
Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells. Acta Biol Med Ger (1979) 0.75
Release of an interferon-like virus inhibitor during contact of mouse leukocytes with target cells. Acta Virol (1970) 0.75
The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells. Ann N Y Acad Sci (1980) 0.75
Interferon-hyporesponsiveness in mice in connection with dose interval and site of administration of Newcastle disease virus. Reflexion in serum complement levels. Acta Virol (1975) 0.75
Twenty years after discovery of interferon: the progress and the persistent problems. Acta Biol Med Ger (1979) 0.75
Decrease of sensitivity to cell-growth inhibitory effect of interferon in human embryo cells after infection with SV40. Acta Virol (1979) 0.75
The effect of interferon induction on complement level in rat. Acta Biol Med Ger (1979) 0.75
[Peritoneal macrophages and interferon formation (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1974) 0.75
The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice. Acta Virol (1979) 0.75
Some properties of interferon released by mouse peritoneal leukocytes stimulated with endotoxin, mannan and Newcastle disease virus in vitro. Acta Virol (1970) 0.75
Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice. Acta Biol Med Ger (1979) 0.75
Some biological activities of rabbit anti-interferon serum. Acta Virol (1976) 0.75
Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice. Acta Virol (1980) 0.75